// App-Quantinova.ai

1544 : Predictors of Response, Adverse Events and Treatment Retention in Ankylosing Spondylitis Patients Treated with Golimumab in a Prospective, Observational Registry

Researchers

Presenter

  • Proton Rahman

Principal Investigators

  • Ariel Masetto

  • Michelle Teo

  • Pauline Boulos

  • Dalton Sholter

  • Suneil Kapur

  • Emmanouil Rampakakis

  • Meagan Rachich

  • Odalis Asin-Milan

  • Allen Lehman

Medical Centers

  • Memorial University, Newfoundland, Canada

  • Universite de Sherbrooke, Sherbrooke, QC, Canada

  • Balfour Medical Clinic, Penticton, BC, Canada

  • McMaster University, Hamilton, ON, Canada

  • Rheumatology Associates, Edmonton, AB, Canada

  • University of Ottawa, Ottawa, ON, Canada

  • JSS Medical Research, Montreal, QC, Canada

  • Janssen Inc., Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

Biomarkers

  • N/A

Drug/Treatment

  • golimumab

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved